Director & 10% Owner Sells $106M in Guardian Pharmacy Secondary Offering
GRDN sits 96% above its 52-week low of $19.17.
Summary
Thomas J. Salentine Jr., a Director and 10% Owner of Guardian Pharmacy Services, sold over 3.57 million shares for approximately $106 million as part of the recently finalized secondary offering.
Key Events · Ownership and Investor Activity · GRDN
-
Significant Insider Sale
Thomas J. Salentine Jr., a Director and 10% Owner, sold 3,570,677 shares of Class A Common Stock.
-
Substantial Proceeds
The sale generated approximately $105.99 million in proceeds for the reporting owner.
-
Part of Secondary Offering at Discounted Price
The transaction was executed on March 20, 2026, as part of the secondary offering finalized on March 23, 2026, at a price of $29.68 per share, which is below the current market price of $37.57.
-
Reduced Stake
This sale reduced Salentine's indirect holdings by 44.41%, with post-transaction holdings of 4,469,316 shares.
Analysis · GRDN · Trade & Services
This Form 4 filing confirms a substantial sale by Thomas J. Salentine Jr., a Director and 10% Owner, as part of the secondary offering that was priced on March 19th and finalized on March 23rd. The sale of over $105 million represents a significant reduction in his indirect holdings, accounting for approximately 4.45% of the company's market capitalization and 44% of his prior stake. The transaction occurred at $29.68 per share, which is a notable discount compared to the current stock price of $37.57, with the company currently trading near its 52-week high. While the market was aware of the secondary offering, this filing provides specific details of a major insider's participation, contributing to the overall insider distribution trend observed in recent filings, including concurrent sales by the CEO and CFO. This large insider sale, even within a pre-announced offering, could be perceived negatively by investors as it signals a substantial reduction in ownership by a key stakeholder.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GRDN was trading at $37.57 on NYSE in the Trade & Services sector, with a market capitalization of approximately $2.4B. The 52-week trading range was $19.17 to $38.12. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.